Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020573

Chief Scientific Officer sold 2,610 shares at an average $0.36 ($953)

  • Chief Scientific Officer acquired 9,092 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Loose Christopher R. · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-07 Sale : show line 1 in the form 10b5-1 −1,306 $0.36 $470 62,781 D
2023-07-07 Exercise or conversion : show line 2 in the form 10b5-1 +4,546 67,327 D
2023-07-10 Sale : show line 3 in the form 10b5-1 −1,304 $0.37 $482 66,023 D
2023-07-10 Exercise or conversion : show line 4 in the form 10b5-1 +4,546 70,569 D
Open-market sales · 2,610 sh · avg $0.36 · $953

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2023-07-07 Exercise or conversion : show line 5 in the form 10b5-1 Restricted Stock Unit −4,546 4,546 136,362 D
2023-07-10 Exercise or conversion : show line 6 in the form 10b5-1 Restricted Stock Unit −4,546 4,546 131,816 D
Loading xslF345X04/form4.xml…